Table 2 Antibiotics in ICU before VAP related enterobacterales according to ESBL-E
Variables | No ESBL-E VAP (n = 476) | ESBL-E VAP (n = 115) | P value |
|---|---|---|---|
Ab in ICU before VAP | 443 (93%) | 112 (97%) | 0.086 |
Penicillins | 207 (44%) | 49 (43%) | 0.86 |
Cephalosporin | 340 (71%) | 90 (78%) | 0.14 |
Fluoroquinolone | 6 (1%) | 6 (5%) | 0.02 |
Carbapenem | 23 (5%) | 9 (8%) | 0.20 |
Aminoglycoside | 42 (9%) | 13 (11%) | 0.41 |
Co-trimoxazole | 7 (1%) | 8 (7%) | 0.001 |
Glycopeptides | 12 (3%) | 8 (7%) | 0.02 |
Linezolid | 30 (6%) | 6 (5%) | 0.66 |
Macrolides | 278 (58%) | 67 (58%) | 0.98 |